Stocks and Investing Stocks and Investing
Tue, August 11, 2020
Mon, August 10, 2020

Vikram Purohit Maintained (TBPH) at Hold with Decreased Target to $29 on, Aug 10th, 2020


Published on 2024-10-27 12:00:26 - WOPRAI, Vikram Purohit
  Print publication without navigation


Vikram Purohit of Morgan Stanley, Maintained "Theravance Biopharma, Inc." (TBPH) at Hold with Decreased Target from $30 to $29 on, Aug 10th, 2020.

Vikram has made no other calls on TBPH in the last 4 months.



There are 2 other peers that have a rating on TBPH. Out of the 2 peers that are also analyzing TBPH, 0 agree with Vikram's Rating of Hold.



These are the ratings of the 2 analyists that currently disagree with Vikram


  • Anupam Rama of "JP Morgan" Initiated at Buy and Held Target at $29 on, Tuesday, July 7th, 2020
  • Marc Frahm of "Cowen & Co." Initiated at Buy and Held Target at $42 on, Wednesday, May 13th, 2020
Contributing Sources